Vimal Mehta, CEO and President: BioXcel Therapeutics BTAIQ Planned sale · Filed 05/20

Trade details

Type: Planned sale notice
Stock: BioXcel Therapeutics BTAIQ
Person: Vimal MehtaCEO and President
Planned sale date: 26/05/20
Filed: 26/05/20

$21.1K to be sold

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 04/20~06/19

Vimal Mehta's recent trades

Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$21.2K
19,419 sh
$21.2K
Filed 05/22
Traded 05/20
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$354
983 sh
$354
Filed 24/12/17
Traded 24/12/16
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$768
2,134 sh
$768
Filed 24/12/17
Traded 24/12/16
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$794
1,150 sh
$794
Filed 24/09/17
Traded 24/09/16
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$574
832 sh
$574
Filed 24/09/17
Traded 24/09/16

Vimal Mehta, CEO — plans to sell 19,419 sh of BioXcel Therapeutics BTAIQ · $21.1K · around 05/20 · 10b5-1 plan | Whalegun